- Current therapeutic options for low-risk papillary thyroid carcinoma:
- A scoping evidence review https://onlinelibrary.wiley.com/doi/abs/10.1002/hed.26883…
- Most cases of thyroid carcinoma are classified as low risk:
- These lesions can be treated with surgery, active surveillance, and percutaneous ablation:
- However, there is lack of consensus and clear indications for a specific treatment selection
- These lesions can be treated with surgery, active surveillance, and percutaneous ablation:
- The objective of this study is to review the literature regarding the indications for management selection for low-risk carcinomas:
- Systematic review exploring inclusion and exclusion criteria used to select patients with low-risk carcinomas for treatment approaches
- The search found 69 studies
- Systematic review exploring inclusion and exclusion criteria used to select patients with low-risk carcinomas for treatment approaches
- The inclusion criteria most reported were nodule diameter and histopathological confirmation of the tumor type
- The most common exclusions were lymph node metastasis and extra-thyroidal extension
- There was significant heterogeneity among inclusion and exclusion criteria according to the analyzed therapeutic approach
- Alternative therapeutic approaches in low-risk carcinomas can be cautiously considered
- Thyroidectomy remains the standard treatment against which all other approaches must be compared
#Arrangoiz #ThyroidSurgeon #ThyroidExpert #EndocrineSurgery #HeadandNeckSurgery #SurgicalOncology #ThyroidCancer #PapillaryThyroidCancer #LowRiskThyroidCancer #Miami #Mexico
Rodrigo Arrangoiz MS, MD, FACS, FSSO 